LncRNA PVT1 promotes cells proliferation via PI3K–AKT–mTOR Pathway in gastrointestinal stromal tumor
暂无分享,去创建一个
[1] Y. Liu,et al. Down‐regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA‐145‐mediated inhibition of FSCN1 , 2019, Molecular oncology.
[2] Ning Zhang,et al. circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] Xiaoyan Li,et al. circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer , 2019, Oncogene.
[4] Z. Zeng,et al. Upregulation and hypomethylation of lncRNA AFAP1‑AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer. , 2019, Oncology reports.
[5] Z. Zeng,et al. Cloning and characterization of the putative AFAP1-AS1 promoter region , 2019, Journal of Cancer.
[6] S. Armstrong,et al. Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition. , 2019, Cancer research.
[7] M. Zhou,et al. Long non-coding RNA LOC284454 promotes migration and invasion of nasopharyngeal carcinoma via modulating the Rho/Rac signaling pathway , 2018, Carcinogenesis.
[8] Robin L. Jones,et al. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] H. Yao,et al. LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis , 2018, Molecular Cancer.
[10] Baiming Liu,et al. Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1. , 2018, Biochemical and biophysical research communications.
[11] Howard Y. Chang,et al. Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element , 2018, Cell.
[12] Mengtao Zhou,et al. LncRNA‐PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR‐448 , 2018, Journal of cellular physiology.
[13] B. Liu,et al. The long non-coding RNA AK001796 contributes to tumor growth via regulating expression of p53 in esophageal squamous cell carcinoma , 2018, Cancer Cell International.
[14] Z. Zeng,et al. Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma , 2018, Cell Death & Disease.
[15] M. McCarter,et al. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.
[16] Lanfang Zhang,et al. Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer. , 2018, American journal of translational research.
[17] Zhi-jun Chen,et al. Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway , 2017, World journal of gastroenterology.
[18] Dapeng Wu,et al. Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195 , 2017, Cellular Physiology and Biochemistry.
[19] Hui Zhang,et al. LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma , 2017, Oncotarget.
[20] Qiang Yu,et al. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[21] Bin Wang,et al. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[22] Long-Bang Chen,et al. The Versatile Role of microRNA-30a in Human Cancer , 2017, Cellular Physiology and Biochemistry.
[23] B. Sitek,et al. Label-free Proteomic Analysis of Exosomes Derived from Inducible Hepatitis B Virus-Replicating HepAD38 Cell Line* , 2017, Molecular & Cellular Proteomics.
[24] K. Søreide,et al. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. , 2016, Cancer epidemiology.
[25] M. Milhem,et al. Imatinib Dosing in Gastrointestinal Stromal Tumors (GISTs): When, How Much, and How Long? , 2015, Current clinical pharmacology.
[26] Ying-ru Zheng,et al. Differential Proteomic Analysis of Syncytiotrophoblast Extracellular Vesicles from Early-Onset Severe Preeclampsia, using 8-Plex iTRAQ Labeling Coupled with 2D Nano LC-MS/MS , 2015, Cellular Physiology and Biochemistry.
[27] Y. Shao,et al. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance , 2015, Tumor Biology.
[28] Jun Zhang,et al. Characterization of Differentially Expressed Genes Involved in Pathways Associated with Gastric Cancer , 2015, PloS one.
[29] H. Huynh,et al. FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors. , 2015, Cancer discovery.
[30] Jie Xu,et al. Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. , 2014, Cancer research.
[31] Xiaoming Jiang,et al. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer , 2014, Cancer.
[32] N. Tanaka,et al. Enhanced Expression of Long Non-Coding RNA HOTAIR Is Associated with the Development of Gastric Cancer , 2013, PloS one.
[33] M. Mourtada-Maarabouni,et al. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. , 2013, Biochimica et biophysica acta.
[34] J. Mattick,et al. Long noncoding RNAs and the genetics of cancer , 2013, British Journal of Cancer.
[35] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[36] D. Spector,et al. Long noncoding RNAs: functional surprises from the RNA world. , 2009, Genes & development.
[37] D. Sabatini,et al. DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.
[38] V. Dangles-Marie,et al. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. , 2006, Human reproduction update.
[39] D. Guertin,et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.
[40] J. Qin,et al. SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.
[41] E. Gaffney,et al. Gastrointestinal stromal tumours , 2003, The British journal of surgery.
[42] S. Hirota,et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. , 2003, Gastroenterology.
[43] L. Sobin,et al. Diagnosis of Gastrointestinal Stromal Tumors:A Consensus Approach , 2002, International journal of surgical pathology.
[44] R K Jain,et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] R. DeMatteo,et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. , 2000, Annals of surgery.
[46] S. Hirota,et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.
[47] G. Lenoir,et al. Breakpoints of burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC , 1994, Genes, chromosomes & cancer.